Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pem and the cost of multicycle maintenance.

× No keyword cloud information.

9 in total

1. Improving quality and addressing the rising costs of cancer care: two birds, one stone.

Authors: Jason Luke; Joshua Mirkin; Peter Bach
Journal: J Oncol Pract Date: 2011-10-18 Impact factor: 3.840

2. Ramucirumab for Colon Cancer and the Problem of Rising Prices Independent of Benefits.

Authors: Peter B Bach
Journal: Oncologist Date: 2015-08-11

3. Variation of Cost among Anti-cancer Drugs Available in Indian Market.

Authors: Bhanu Prakash Kolasani; Divyashanthi Chellathambi Malathi; Raghunatha Rao Ponnaluri
Journal: J Clin Diagn Res Date: 2016-11-01

4. The high cost of cancer drugs and what we can do about it.

Authors: Mustaqeem Siddiqui; S Vincent Rajkumar
Journal: Mayo Clin Proc Date: 2012-10 Impact factor: 7.616

Review 5. Maintenance chemotherapy for advanced non-small-cell lung cancer: new life for an old idea.

Authors: David E Gerber; Joan H Schiller
Journal: J Clin Oncol Date: 2013-02-11 Impact factor: 44.544

Review 6. Maintenance treatment after induction therapy in non-small cell lung cancer: latest evidence and clinical implications.

Authors: Ryan D Gentzler; Jyoti D Patel
Journal: Ther Adv Med Oncol Date: 2014-01 Impact factor: 8.168

7. Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer.

Authors: Alain Vergnenègre; Joshua A Ray; Christos Chouaid; Francesco Grossi; Helge G Bischoff; David F Heigener; Stefan Walzer
Journal: Clinicoecon Outcomes Res Date: 2012-01-26

Review 8. Role of Gemcitabine and Pemetrexed as Maintenance Therapy in Advanced NSCLC: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors: Xingsheng Hu; Ke Pu; Xuqin Feng; Shimin Wen; Xi Fu; Cuihua Guo; Wenwu He
Journal: PLoS One Date: 2016-03-08 Impact factor: 3.240

9. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.

Authors: Yulei Zhu; Ying Wang; Xiaoluan Sun; Xin Li
Journal: Int J Environ Res Public Health Date: 2019-10-03 Impact factor: 3.390

9 in total